Semaglutide authorised as Ozempic is not currently recognised by regulators as causing specific vulvovaginal adverse reactions such as vaginal dryness, vulvovaginal candidiasis, altered discharge, dyspareunia, vaginal atrophy, or vaginal mucosal injury
They aren't just rebranding a mystery powder from an overseas wholesaler
Drugs } : CS1 maint: overridden setting (link) "Do incretin-based therapies cause acute pancreatitis?"
With its ability to recognise and selectively eliminate senescent cells without damaging the surrounding tissue, FOXO4-DRI is among the molecular tools shaping a new generation of therapeutic approaches focused on anti-aging and regeneration
it addresses both the cellular trigger (oxidative stress in the mast cell) and the systemic clearance mechanism (hepatic detoxification)
A therapy that reduces appetite while also improving liver fat metabolism could have advantages beyond weight reduction alone